Sol-Gel Technologies Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sol-Gel Technologies Ltd
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
/ 
Frequently asked questions
To buy Sol-Gel Technologies Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sol-Gel Technologies Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sol-Gel Technologies Ltd is SLGL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sol-Gel Technologies Ltd has its primary listing on NASDAQ. You can trade Sol-Gel Technologies Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sol-Gel Technologies Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Sol-Gel Technologies Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Sol-Gel Technologies Ltd.